Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

CURABIS ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   11.2% 16.6% 9.3% 11.8% 14.5% 11.5% 13.4% 13.4%   Credit score (0-100)   23 10 25 19 14 21 17 17   Credit rating   BB BB BB BB BB BB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   2,245 2,849 4,786 4,362 3,615 5,331 0.0 0.0   EBITDA   202 381 1,041 158 -379 1,269 0.0 0.0   EBIT   202 381 1,041 47.1 -495 1,153 0.0 0.0   Pre-tax profit (PTP)   197.6 378.1 1,035.6 34.8 -497.5 1,108.2 0.0 0.0   Net earnings   153.8 322.0 807.1 25.8 -390.1 860.6 0.0 0.0   Pre-tax profit without non-rec. items   198 378 1,036 34.8 -498 1,108 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   0.0 0.0 0.0 93.9 96.2 72.4 0.0 0.0   Shareholders equity total   204 171 978 504 63.9 925 731 731   Interest-bearing liabilities   91.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,220 2,135 2,881 2,175 1,580 2,569 731 731   Net Debt   -400 -320 -1,639 -459 -282 -253 -731 -731     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   2,245 2,849 4,786 4,362 3,615 5,331 0.0 0.0   Gross profit growth   -0.6% 26.9% 68.0% -8.9% -17.1% 47.5% -100.0% 0.0%   Employees   0 0 6 6 6 6 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,220 2,135 2,881 2,175 1,580 2,569 731 731   Balance sheet change%   22.2% 75.1% 34.9% -24.5% -27.4% 62.5% -71.6% 0.0%   Added value   201.6 380.8 1,041.3 157.8 -383.9 1,268.7 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 352 -205 -232 -257 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 -1.0 1.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   9.0% 13.4% 21.8% 1.1% -13.7% 21.6% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   18.2% 22.7% 41.5% 1.9% -26.3% 55.6% 0.0% 0.0%   ROI %   62.0% 163.4% 181.2% 6.3% -171.4% 223.7% 0.0% 0.0%   ROE %   69.9% 171.7% 140.4% 3.5% -137.4% 174.1% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   18.7% 8.4% 42.3% 25.2% 4.4% 38.4% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -198.5% -84.0% -157.4% -290.9% 74.4% -20.0% 0.0% 0.0%   Gearing %   44.7% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   3.7% 6.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   1.3 1.1 2.2 1.1 0.8 1.6 0.0 0.0   Current Ratio   1.2 1.1 1.5 1.0 0.8 1.4 0.0 0.0   Cash and cash equivalent   491.2 319.7 1,639.0 459.1 282.2 253.2 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   179.7 171.2 978.3 -2.2 -366.9 650.5 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 174 26 -64 211 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 174 26 -63 211 0 0   EBIT / employee   0 0 174 8 -82 192 0 0   Net earnings / employee   0 0 135 4 -65 143 0 0